1-(Bromomethyl)-4-[1-[(2-methylpropan-2-yl)oxy]ethenyl]benzene

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(Bromomethyl)-4-[1-[(2-methylpropan-2-yl)oxy]ethenyl]benzene
• 英文别名: 1-(bromomethyl)-4-[1-[(2-methylpropan-2-yl)oxy]ethenyl]benzene
• 化学式: C₁₃H₁₇BrO
• 分子量: 269.18
• InChiKey: OEIBZZOJJUIXCP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] METALLOCENE COMPOUNDS AND LABELED MOLECULES COMPRISING THE SAME FOR IN VIVO IMAGING<br/>[FR] COMPOSÉS MÉTALLOCÈNES ET MOLÉCULES MARQUÉES LES COMPRENANT POUR IMAGERIE IN VIVO
  申请人：APTENIA S R L

  公开号：WO2014135590A1

  公开（公告）日：2014-09-12

  The present invention concerns compounds and methods of labeling peptides or other molecules with 18F or 19F or any other suitable radionuclide of use, for example, in PET or NMR in vivo imaging. A targeting molecule such as a protein or a peptide is linked to a substituted metallocene complex which is reacted with the lgF or 19F shortly before performing the PET or NMR in vivo imaging on the patient. The labeled molecule is then used for targeting a cell, tissue, organ or pathogen to be imaged or detected.